Sernova Corp
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- -
- Employees
- 3K
- Market Cap
- -
- Introduction
Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation
Phase 1
Recruiting
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2018-05-02
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Sernova Corp
- Target Recruit Count
- 17
- Registration Number
- NCT03513939
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
News
No news found